Microbicidal spermicide or spermicidal microbicide?

European Journal of Contraception and Reproductive Health Care

Volumn 10, Issue 4, 2005, Pages 212-218

  Gupta, Gopal ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Contraception; HIV; Microbicide; Spermicide; STD

Indexed keywords

CALANOLIDE A; CELLACEFATE; CELLULOSE SULFATE; CYANOVIRIN N; DEXTRIN 2 SULFATE; DITHIOCARBAMIC ACID DERIVATIVE; HUMAN MONOCLONAL ANTIBODY; ISOXAZOLE DERIVATIVE; ISOXAZOLINE DERIVATIVE; MANDELIC ACID; MICROBICIDE; MONOCLONAL ANTIBODY C2F5; MONOCLONAL ANTIBODY C2G12; MONOCLONAL ANTIBODY C4E10; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; NONOXINOL 9; PHENOL DERIVATIVE; PLANT EXTRACT; PLANTIBODY; POLYMETHYLENE HYDROQUINONE SULFONATE; POLYSTYRENESULFONIC ACID; PORPHYRIN; QUINONE DERIVATIVE; SAPINDUS MUKOROSSI EXTRACT; SAPONIN DERIVATIVE; SPERMICIDAL AGENT; SULFATE; SULFONIC ACID DERIVATIVE; TENOFOVIR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL GROWTH; CLINICAL TRIAL; CONDOM; DRUG ACTIVITY; DRUG MECHANISM; FEMALE CONTRACEPTIVE DEVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; SEXUALLY TRANSMITTED DISEASE; TREATMENT OUTCOME; UNWANTED PREGNANCY; VAGINA CONTRACEPTION;

ADMINISTRATION, INTRAVAGINAL; ANTI-INFECTIVE AGENTS, LOCAL; CLINICAL TRIALS; CONTRACEPTIVE AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INDIA; PREGNANCY; SEXUALLY TRANSMITTED DISEASES; SPERMATOCIDAL AGENTS;

EID: 32144433515     PISSN: 13625187     EISSN: 14730782     Source Type: Journal    
DOI: 10.1504/IJBT.2005.006455     Document Type: Review

References (60)

1. Alexander, NJ. Barriers to sexually transmitted diseases. Sci Am Sci Med 1996;3:32-41.
2. Baron S, Poast J, Nguyen D, et al. Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: use of commercial lubricants. AIDS Res Hum Retroviruses 2001;17:997-1002.
3. Blocker ME, Cohen MS. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus. Infect Dis Clin North Am 2000;14:983-99.
4. Washington AE, Gove S, Schachter J, et al. Oral contraceptives, Chlamydia trichomatis infection and pelvic inflammatory disease. A word of caution about protection. JAMA 1985;253:2246-50.
5. Avonts D, Sercu M, Heyerick P, et al. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 1990;17:23-9.
6. Guerreiro D, Gigante MA, Teles LC. Sexually transmitted diseases and reproductive tract infections among contraceptive users. Int J Gynaecol Obstet 1998;63(Suppl 1):S167-73.
7. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
8. Trager RS. Raising new barriers against HIV infection. Science 2003;299:39.
9. Piret J, Desmormeaux A, Bergeron MG. Sodium lauryl sulfate, a microbicide effective against enveloped and non-enveloped viruses. Curr Drug Targets 2002;3:17-30.
10. Ballweber LM, Jaynes JE, Stamm WE, et al. In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trichomatis. Antimicrob Agents Chemother 2002;46:34-41.
11. Mauck C, Doncel G. An update on vaginal microbicides. Curr Infect Dis Rep 2001;3:561-8.
12. Rabe LK, Hillier SL. Effect of chlorhexidine on genital microflora, Neisseria gonorrhoeae and Trichomonas vaginalis in vitro. Sex Transm Dis 2000;27:74-8.
13. Rosenstein IJ, Stafford MK, Kitchen VS, et al. Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998;177:1386-90.
14. Dailard C. Abortion in Context: United States and Worldwide, Issues in Brief. New York: The Alan Guttmacher Institute, 1999, No. 1.
15. Forrest JD. Timing of reproductive life stages. Obstet Gynecol 1993;82:105-11.
16. Bernstein GS. Physiological aspects of vaginal contraception. Contraception 1974;9:333-45.
17. Lee CH. Review: In vitro spermicidal tests. Contraception 1996;54:131-47.
18. Wainberg MA, Spira B, Bleau G, et al. Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. J Clin Microbiol 1990;28:156-8.
19. Jones BM, Willcox LM. The susceptibility of organisms associated with bacterial vaginosis to spermicidal compounds, in vitro. Genitourin Med 1991;67:475-7.
20. Patton DL, Kidder GG, Sweeney YC, Rabe LK, Clark AM, Hillier SL. Effects of nonoxynol-9 on vaginal microflora and Chlamydial infection in a monkey model. Sex Transm Dis 1996;23:461-4.
21. Roddy RE, Zekeng L, Ryan KA, et al. Effect of nonoxynol-9 gel on urogenital gonorrhea and chlamydial infection: A randomized controlled trial. JAMA 2002;287:1117-22.
22. Kirby J. Nonoxynol-9 may increase HIV tranmission risk. Posit Living 2001;10:20.
23. Richardson BA, Lavreys L, Martin HL Jr, et al. Evaluation of a low dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: A randomized clinical trial. Sex Transm Dis 2001;28:394-400.
24. Forbes A, Heise L. What's up with nonoxynol-9? Reprod Health Matters 2000;8:156-9.
25. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial infections. Lancet 1992;339:1371-5.
26. Stafford MK, Ward H, Flanagan A, et al. Safety study of N-9 as a vaginal microbicide: evidence of adverse effects. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:327-31.
27. Patton DL, Kidder GG, Sweeney YC, et al. Effect of multiple applications of benzalkonium chloride and N-9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). Am J Obstet Gynecol 1999;180:1080-7.
28. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of N-9 induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 2001;184:418-28.
29. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 2002;29:655-64.
30. Kreiss J, Ngugi E, Holmes K, et al. Efficiency of N-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1993;268:477-82.
31. Uckun FM, D'Cruz OJ. Prophylactic contraceptives for HIV/AIDS. Hum Reprod Update 1999;5:506-14.
32. Watts DH, Rabe L, Krohn MA, et al. The effects of three N-9 preparations on vaginal flora and epithelium. J Infect Dis 1999;180:426-37.
33. McGroarty JA, Tomeczek L, Pond DG, et al. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound N-9. J Infect Dis 1992;165:1142-4.
34. Klebanoff SJ. Effects of the spermicidal agent N-9 on vaginal microbial flora. J Infect Dis 1992;165:19-25.
35. Hooton TM, Fennel CL, Clark AM, et al. N-9: differential anti-bacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. J Infect Dis 1991;164:1216-9.
36. Neri A, Rabinerson D, Kaplan B. Bacterial vaginosis: drugs versus alternative treatment. Obstet Gynecol Surv 1994;49:809-13.
37. Brzezinski A, Stern T, Arbel R, et al. Efficacy of a novel pH-buffering tampon in preserving the acidic vaginal pH during menstruation. Int J Gyn Obs 2004;85:298-300.
38. Oshio S, Ozaki S, Ohkawa I, et al. Spermicidal activity of menfegol - coated condom. Andrologia 1990;22:291-296.
39. Rastogi SN, Kulshreshtha DK. Fertility regulation. In Rastogi SN, Kulshreshtha DK, eds. Fifty Years of Research and Development 1951-2001, Vol 2, Drug Development. Lucknow, India: Central Drug Research Institute, 2001:1-60.
40. Srivastava S, Bajpai LK, Batra S, et al. In search of new chemical entities with anti-HIV activities. Biorg Med Chem 1999;7:2607-13.
41. Kumaria N, Dwivedi AK, Maikhuri JP, et al. Substituted acrylophenones and related mannich bases as possible spermicides and inhibitors of HIV envelope glycoprotein-CD4 interaction. Eur J Med Chem 2002;37:855-864.
42. Tripathi RP, Khan AR, Setty BS, et al. Synthesis and spermicidal activities of diethyldithiocarbamate. Acta Pharm 1996;46;169-76.
43. Garg S, Doncel G, Chabra S, et al. Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride. Contraception 1994;50:185-90.
44. Setty BS, Kamboj VP, Garg HS, et al. Spermicidal potential of saponins isolated from Indian plants. Contraception 1976;14:571-8.
45. Setty BS, Kamboj VP, Khanna NM. Screening of Indian plants for biological activity: Part VII - Spermicidal activity of Indian plants. Indian J Exp Biol 1977;15:231-2.
46. Zeitlin L, Whaley KJ. Microbicides for preventing transmission of genital herpes. Herpes 2002;9:4-9.
47. van De Wijgert J, Fullem A, Kelly C, et al. Phase 1 trial of the topical microbicide BefferGel: safety results from four international sites. J Acquir Immune Defic Syndr 2001;26:21-7.
48. Mayer KH, Peipert J, Fleming T, et al. Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Inject Dis 2001;32:476-82.
49. Garg S, Anderson RA, Chany CJ, et al. Properties of a new acid-buffering bioadhesive vaginal formulation (ACIDFORM). Contraception 2001;64:67-75.
50. D'Cruz OJ, Venkatachalam TK, Zhu Z, et al. Aryl phosphate derivatives of bromo-methoxy-azidothymidine are dual function spermicides with potent anti-human immunodeficiency virus. Biol Reprod 1998;59:503-15.
51. D'Cruz OJ, Shih MJ, Yiv SH, et al. Synthesis, characterization and pre-clinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy ziduvudine (compound WHI-07) with potent anti-HIV and spermicidal activities. Mol Hum Reprod 1999;5:421-32.
52. D'cruz OJ, Zhu Z, Yiv SH, et al. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual action spermicide with potent anti-HIV activity. Contraception 1999;59:319-31.
53. D'Cruz OJ, Venkatachalam TK, Uckun FM. Structural requirements for potent human spermicidal activity of dual function aryl phosphate derivative of bromomethoxy zidovudine (compound WHI-07). Biol Reprod 2000;62:37-44.
54. D'Cruz OJ, Waurzyniak B, Yiv SH, et al. Evaluation of subchronic (13 weeks) and reproductive toxicity potential of intravaginal gel microemulsion formulation of a dual function phenyl phosphate derivative of bromomethoxy zidovudine (compound WHI-05) in B(6)C(3) F(1) mice. Contraception 2000;61:69-76.
55. D'Cruz OJ, Waurzyniak B, Yiv SH, et al. Evaluation of subchronic (13 weeks) and reproductive toxicity potential of intravaginal gel microemulsion formulation of a dual function phenyl phosphate derivative of bromomethoxy zidovudine (compound WHI-07) in B(6)C(3)F(1) mice. J Appl Toxicol 2000;20:319-25.
56. D'Cruz OJ, Uckun FM. Lack of adverse effects on fertility of female CD-1 mice exposed to repetitive intravaginal gel-microemulsion formulation of a dual-function anti-HIV agent: aryl phosphate derivative of bromo-methoxy- zidovudine (compound WHI-07). J Appl Toxicol 2001;21:317-22.
57. D'Cruz OJ, Venkatachalani TK, Uckun FM. Novel thiourea compounds as dual-function microbicides. Biol Reprod 2000;63:196-205.
58. D'Cruz OJ, Venkatachalam TK, Mao C, et al. Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase. Biol Reprod 2002;67:1959-74.
59. Mauck C, Weiner DH, Ballagh S, et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a phase I safety and colposcopy study. Contraception 2001;64:383-91.
60. des Vignes F. The microbicide research and development database (MRDD): a better tool for the field. In: des Vignes F, Lamphear TL, eds. The Microbicide Quarterly, Vol 2(1). Silver Spring, USA: Alliance for Microbicide Development, 2004:1-5.